Clinical decision-support only. For use by licensed dental professionals. Not a substitute for professional judgment or a complete drug reference. Always verify with primary sources.
← Back to search
Condition

HIV / AIDS

Infectious / Immunologic

Likelihood of oral impactHigh

How likely this condition is to affect the mouth.

Evidence confidenceHigh

Strength of the peer-reviewed evidence.

Oral health effects

  • Oral thrush (candidiasis)

    Common opportunistic infection, often an early sign of immune suppression.

    Clinical management: Antifungal therapy; assess immune status.

  • White ridged patches on the sides of the tongue (oral hairy leukoplakia)

    EBV-associated white lesion on the lateral tongue, fairly specific to immunosuppression. Much less common in patients on effective antiretroviral therapy.

    Clinical management: Usually no treatment needed; reflects immune status.

  • Dry mouth and salivary gland swelling (HIV-associated salivary gland disease)

    Chronic dry mouth is one of the most common oral problems in HIV, from salivary gland disease and from medications; parotid enlargement may also occur.

    Clinical management: Ask about dryness; recommend sugar-free saliva substitutes, frequent water sips, high-fluoride toothpaste and caries-risk recall intervals.

  • Oral warts (HPV)

    Cauliflower-like white, grey or pink bumps on the lips, gingiva or mucosa caused by human papillomavirus; can persist or even increase despite antiretroviral therapy.

    Clinical management: Document and photograph; refer for removal (surgical, cryotherapy); note they can recur; avoid traumatizing lesions during instrumentation.

  • Red band along the gum line (linear gingival erythema)

    A distinct fiery-red band along the marginal gingiva that bleeds easily and responds poorly to plaque control alone; often Candida-associated.

    Clinical management: Do thorough debridement plus chlorhexidine rinse; refer for antifungal therapy if it does not resolve; monitor as a possible marker of immune status.

  • Cold sores and mouth ulcers (herpes / aphthous ulcers)

    Recurrent herpes and canker-sore-type ulcers are more frequent and can be larger and slower to heal with immunosuppression.

    Clinical management: Postpone elective care during active herpes lesions; refer large (>1 cm) or non-healing ulcers for evaluation; offer topical anesthetic/protective agents.

  • Dark patches in the mouth from HIV medicines (oral hyperpigmentation)

    Brown-to-black mucosal pigmentation occurs in about a quarter of people on antiretroviral therapy (especially NRTIs); it is harmless but can be mistaken for other pigmented lesions.

    Clinical management: Record location and appearance at baseline; reassure; refer any solitary, raised, growing or irregular pigmented lesion for evaluation.

  • Rapidly destructive, painful gum disease (necrotizing periodontal disease)

    Necrotizing gingivitis and periodontitis are more likely with advanced immunosuppression.

    Clinical management: Prompt debridement and periodontal care; coordinate with the patient's HIV care team.

  • Purple or red mouth tumors (Kaposi sarcoma)

    An HIV-associated malignancy that can appear in the mouth.

    Clinical management: Refer suspicious lesions for biopsy.

Sources

  1. Urban legends series: oral manifestations of HIV infection. Patton LL, Ramirez-Amador V, Anaya-Saavedra G, et al. Oral diseases, 2013.
  2. The global changing pattern of the oral manifestations of HIV. Tappuni AR. Oral diseases, 2020.
  3. Oral manifestations in HIV-positive individuals under highly active antiretroviral therapy: a systematic review and meta-analysis of prevalence data. Dagnoni TS, Paranhos LR, de Almeida VL, et al. BMC oral health, 2026.
  4. HIV/AIDS & Oral Health National Institute of Dental and Craniofacial Research (NIH), 2024.
  5. Periodontal disease in HIV/AIDS. Ryder MI, Nittayananta W, Coogan M, et al. Periodontology 2000, 2012.
  6. Impact of highly active antiretroviral therapy on the prevalence of oral lesions in HIV-positive patients: a systematic review and meta-analysis. de Almeida VL, Lima IFP, Ziegelmann PK, et al. International journal of oral and maxillofacial surgery, 2017.
  7. Oral hyperpigmentation as an adverse effect of highly active antiretroviral therapy in HIV patients: A systematic review and pooled prevalence. Radithia D, Subarnbhesaj A, Ayuningtyas NF, et al. Journal of clinical and experimental dentistry, 2023.